IRIS
ARCESE, WILLIAM
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 69.298
AS - Asia 7.586
EU - Europa 6.150
SA - Sud America 1.181
Continente sconosciuto - Info sul continente non disponibili 622
AF - Africa 119
OC - Oceania 14
Totale 84.970
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 68.956
SG - Singapore 3.542
CN - Cina 1.448
DE - Germania 1.195
IT - Italia 972
RU - Federazione Russa 941
BR - Brasile 935
UA - Ucraina 796
HK - Hong Kong 794
IE - Irlanda 712
VN - Vietnam 569
GB - Regno Unito 354
FR - Francia 342
BD - Bangladesh 295
KR - Corea 288
FI - Finlandia 241
SE - Svezia 240
JP - Giappone 176
CA - Canada 148
IN - India 114
PL - Polonia 94
AR - Argentina 89
MX - Messico 63
NL - Olanda 59
ES - Italia 41
ZA - Sudafrica 41
IQ - Iraq 40
AT - Austria 38
JM - Giamaica 33
CO - Colombia 32
CR - Costa Rica 32
EC - Ecuador 31
ID - Indonesia 31
TR - Turchia 30
UZ - Uzbekistan 28
PH - Filippine 27
PK - Pakistan 26
BE - Belgio 24
VE - Venezuela 23
MY - Malesia 22
MA - Marocco 21
CL - Cile 20
CZ - Repubblica Ceca 18
PY - Paraguay 18
SA - Arabia Saudita 17
TH - Thailandia 17
AE - Emirati Arabi Uniti 16
UY - Uruguay 15
EU - Europa 14
IR - Iran 14
KE - Kenya 14
AU - Australia 12
IL - Israele 12
PE - Perù 12
HN - Honduras 11
NP - Nepal 11
KZ - Kazakistan 10
LT - Lituania 10
BY - Bielorussia 9
PA - Panama 9
DZ - Algeria 8
NG - Nigeria 8
NI - Nicaragua 8
PT - Portogallo 8
TW - Taiwan 8
AL - Albania 7
EG - Egitto 7
GT - Guatemala 7
JO - Giordania 7
TN - Tunisia 7
TT - Trinidad e Tobago 7
CH - Svizzera 6
EE - Estonia 6
KG - Kirghizistan 6
SV - El Salvador 6
AZ - Azerbaigian 5
BG - Bulgaria 5
BO - Bolivia 5
DK - Danimarca 5
GR - Grecia 5
HU - Ungheria 5
RO - Romania 5
AM - Armenia 4
BS - Bahamas 4
LB - Libano 4
SN - Senegal 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BB - Barbados 3
LK - Sri Lanka 3
PR - Porto Rico 3
QA - Qatar 3
AW - Aruba 2
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
CY - Cipro 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GE - Georgia 2
HR - Croazia 2
KH - Cambogia 2
Totale 84.332
Salva come PNG Salva come JPEG
Città #
Wilmington 17.997
Woodbridge 17.266
Houston 16.023
Fairfield 2.123
Singapore 1.819
Ashburn 1.701
Ann Arbor 1.508
San Jose 1.110
Chandler 943
Seattle 818
Hong Kong 778
Cambridge 725
Jacksonville 692
Dublin 686
Beijing 615
Medford 535
Dearborn 455
Santa Clara 359
New York 314
Council Bluffs 286
The Dalles 268
Lawrence 253
Rome 253
Los Angeles 216
Moscow 195
Lauterbourg 185
Ho Chi Minh City 178
San Diego 152
Buffalo 146
Tokyo 139
Hanoi 133
Dallas 130
Regensburg 128
Mülheim 105
Milan 100
São Paulo 92
Helsinki 86
Orem 72
Zhengzhou 68
Menlo Park 62
Chicago 61
London 61
Denver 58
Munich 57
Atlanta 52
Norwalk 45
Kraków 42
Warsaw 41
Redwood City 40
Boardman 37
Hefei 37
Redondo Beach 37
Toronto 37
Falls Church 36
Guangzhou 36
Nuremberg 36
Brooklyn 34
University Park 34
Nanjing 33
Frankfurt am Main 32
Hangzhou 31
Phoenix 29
Detroit 28
Montreal 28
San José 28
Haiphong 27
Johannesburg 27
Chennai 26
North Bergen 26
Rio de Janeiro 25
Saint Petersburg 25
Seoul 25
Kunming 24
Philadelphia 24
Da Nang 23
Kingston 23
Redmond 23
San Francisco 23
Belo Horizonte 22
Washington 22
Brussels 20
Mountain View 20
Mumbai 20
Naples 19
Shanghai 19
Columbus 18
Poplar 18
Verona 18
Jakarta 17
New Delhi 17
Tashkent 17
Brno 16
Bari 15
Brasília 15
Charlotte 15
Nanchang 15
Baghdad 14
Bogotá 14
Elk Grove Village 14
Las Vegas 14
Totale 71.404
Salva come PNG Salva come JPEG
Nome #
Unrelated cord blood transplant in children with high-risk acute lymphoblastic leukemia: a long-term follow-up 699
Toward optimization of postremission therapy for residual disease-positive patients with acute myeloid leukemia 651
Persistent risk of HBV reactivation despite extensive lamivudine prophylaxis in haematopoietic stem cell transplant recipients who are anti-HBc-positive or HBV-negative recipients with an anti-HBc-positive donor 593
Pre-transplant prognostic factors for patients with high-risk leukemia undergoing an unrelated cord blood transplantation 576
Treatment of acute graft-versus-host disease with prednisolone: significant survival advantage for day+5 responders and no advantage for nonresponders receiving anti-thymocyte globulin 549
Peripheral blood stem cell collection from G-CSF-stimulated unrelated donors for second transplant 536
Bowel ultrasonography as an aid for diagnosis of intestinal acute graft-versus-host-disease after allogeneic haematopoietic stem cell transplantation 527
A prospective molecular study of chimaerism in patients with haematological malignancies receiving unrelated cord blood or bone marrow transplants: detection of mixed chimaerism predicts graft failure with or without early autologous reconstitution in cord blood recipients 503
High levels of antiphospholipid antibodies are associated with cytomegalovirus infection in unrelated bone marrow and cord blood allogeneic stem cell transplantation 499
Hematopoietic stem cell transplantation for adults with acute promyelocytic leukemia in the ATRA era: a survey of the European Cooperative Group for Blood and Marrow Transplantation 498
High incidence of post-transplant cytomegalovirus reactivations in myeloma patients undergoing autologous stem cell transplantation after treatment with bortezomib-based regimens: a survey from the Rome transplant network. 495
High expression levels of vla-4 (CD49d) on mobilised peripheral blood stem cells are associated with rapid engraftment in multiple myeloma patients receiving autologous transplant 494
Hematopoietic, Mesenchymal, and Immune Cells Are More Enhanced in Bone Marrow than in Peripheral Blood from Granulocyte Colony-Stimulating Factor Primed Healthy Donors 493
A new system for quality control in hematopoietic progenitor cell units before reinfusion in autologous transplant 489
ALL R-87 protocol in the treatment of children with acute lymphoblastic leukaemia in early bone marrow relapse 482
Fibrin glue for refractory hemorrhagic cystitis after unrelated marrow, cord blood, and haploidentical hematopoietic stem cell transplantation 481
Factors associated with outcomes of unrelated cord blood transplant: guidelines for donor choice 479
Post-transplant cyclophosphamide versus anti-thymocyte globulin as graft- versus-host disease prophylaxis in haploidentical transplant 479
Splenic irradiation before hematopoietic stem cell transplantation for chronic myeloid leukemia: long-term follow-up of a prospective randomized study 477
3-Tesla MR spectroscopy in patients subjected to bone marrow transplantation: clinical correlations. 476
Cord blood transplantation in adults with acute myeloid leukaemia. 475
A fatal case of invasive fungal sinusitis by Scopulariopsis acremonium in a bone marrow transplant recipient 475
Impact of ABO incompatibility on patient outcome in haploidentical hematopoietic stem cell transplantation for acute myeloid leukemia - a report from the acute leukemia working party of the EBMT 471
Allogeneic hematopoietic stem cell transplantation in patients with diffuse large B cell lymphoma relapsed after autologous stem cell transplantation: a GITMO study 469
Clinical and metabolic effects of different parenteral nutrition regimens in patients undergoing allogeneic bone marrow transplantation 469
Monitoring of KI and WU polyomaviruses in hematopoietic stem cell transplant patients 468
The policy of the Rome Transplant Network (RTN), a metropolitan (2009). The Potential Application Of The Allogeneic Transplant By The Policy Of Widespread Donor Search: An Intention-To-Treat Analysis From The Rome Transplant Network. 468
The potential role of pre-transplant HBcIgG seroposivity as predictor of clinically relevant cytomegalovirus infection in patients with lymphoma undergoing autologous hematopoietic stem cell transplantation: A study from the Rome Transplant Network 467
Cryotherapy reduces oral mucositis and febrile episodes in myeloma patients treated with high-dose melphalan and autologous stem cell transplant: a prospective, randomized study 464
Factors predicting outcome after allogeneic transplant in refractory acute myeloid leukemia: a retrospective analysis of Gruppo Italiano Trapianto di Midollo Osseo (GITMO) 462
Ponatinib Induces a Persistent Molecular Response and Graft-versus-Host Disease/Graft-versus-Leukemia Effect in a Patient with Philadelphia-Positive Acute Lymphoblastic Leukemia with a T315I Mutation following Early Relapse after Allogeneic Transplant 461
Excretion of the novel polyomaviruses KI and WU in the stool of patients with hematological disorders 460
WHO classification and WPSS predict posttransplantation outcome in patients with myelodysplastic syndrome: a study from the Gruppo Italiano Trapianto di Midollo Osseo (GITMO) 457
Obstacles to managing chemotherapy-induced nausea and vomiting in high-dose chemotherapy with stem cell transplant 456
The therapeutic use of cord blood 454
Pre-transplant manipulation processing of umbilical cord blood units: Efficacy of Rubinstein's thawing technique used in 40 transplantation procedures 453
Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation 452
Platelet gel for treatment of mucocutaneous lesions related to graft-versus-host disease after allogeneic hematopoietic stem cell transplant 450
Sezary syndrome in relapse after reduced intensity allogeneic transplant successfully treated with donor lymphocyte infusion 450
Histone deacetylase inhibitor valproic acid enhances the cytokine-induced expansion of human hematopoietic stem cells 448
Fractionated total body irradiation in allogeneic bone marrow transplantation in leukemia patients: analysis of prognostic factors and results in 136 patients 445
Thiotepa-based conditioning for allogeneic stem cell transplantation in acute lymphoblastic leukemia—A survey from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation 445
Pre-transplant persistence of minimal residual disease does not contraindicate allogeneic stem cell transplantation for adult patients with acute myeloid leukemia 443
A comparison between allogeneic stem cell transplantation from unmanipulated haploidentical and unrelated donors in acute leukemia 442
Thrombophilic screening in patients with paroxysmal nocturnal haemoglobinuria: a pilot study 440
Increasing risk of relapse after allogeneic stem cell transplant for adult acute lymphoblastic leukemia in > or = 2nd complete remission induced by highly intensive chemotherapy 440
CD34+ cell mobilization for allogeneic progenitor cell transplantation: efficacy of a short course of G-CSF 438
Higher incidence of relapse in patients with acute myelocytic leukemia infused with higher doses of CD34+ cells from leukapheresis products autografted during the first remission. 437
Stem cell transplantation for chronic myeloid leukemia in children 437
Pregnancy and secondary cancer after allogeneic bone marrow transplantation 436
Transplantation of peripheral blood stem cells as compared with bone marrow from HLA-identical siblings in adult patients with acute myeloid leukemia and acute lymphoblastic leukemia 436
Algorithm for donor selection in 2011 435
Impact of conditioning intensity in T-replete haplo-identical stem cell transplantation for acute leukemia: a report from the acute leukemia working party of the EBMT 435
ABO-incompatible bone marrow transplantation: a GITMO survey of current practice in Italy and comparison with the literature 434
Gastrointestinal surgical emergencies in patients treated for hemathological malignancies 434
Allogeneic stem cell transplantation for patients with advanced primary cutaneous T-cell lymphoma 433
Cidofovir for BK virus-associated hemorrhagic cystitis: a retrospective study 432
Prognostic and therapeutic implications of minimal residual disease detection in acute myeloid leukemia. 432
Early treatment of acute graft-versus-host disease with high- or low-dose 6-methylprednisolone: a multicenter randomized trial from the Italian Group for Bone Marrow Transplantation 432
The Rome Transplant Network model compared to the Italian Bone Marrow Donor Registry activity for unrelated donor search process and transplant efficiency for hematologic malignancy 432
Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia:a retrospective analysis. 431
HLA-identical sibling allogeneic peripheral blood stem cell transplantation with reduced intensity conditioning compared to autologous peripheral blood stem cell transplantation for elderly patients with de novo acute myeloid leukemia 431
Factors associated with outcome after cord blood transplantation in children with acute leukemia. Eurocord-Cord Blood Transplant Group 429
Cytogenetic and molecular diagnostic characterization combined to post-consolidation minimal residual disease assessment by flow-cytometry improves risk stratification in adult acute myeloid leukemia 427
Impact of Graft-versus-Host Disease Prophylaxis on Outcomes after Myeloablative Single-Unit Umbilical Cord Blood Transplantation 427
Matched and mismatched unrelated donor compared to autologous stem cell transplantation for acute myeloid leukemia in first complete remission: a retrospective, propensity score-weighted analysis from the ALWP of the EBMT 425
Cyclosporin A and short-term methotrexate versus cyclosporin A as graft versus host disease prophylaxis in patients with severe aplastic anemia given allogeneic bone marrow transplantation from an HLA-identical sibling: results of a GITMO/EBMT randomized trial 424
Treatment of severe aplastic anemia with antilymphocyte globulin, cyclosporine and two different granulocyte colony-stimulating factor regimens: a GITMO prospective randomized study 424
Evaluation of a disease risk index for adult patients undergoing umbilical cord blood transplantation for haematological malignancies 424
Hospital cluster of HBV infection: molecular evidence of patient-to-patient transmission through lancing device 423
Marrow versus peripheral blood for geno-identical allogeneic stem cell transplantation in acute myelocytic leukemia: influence of dose and stem cell source shows better outcome with rich marrow 423
Standard versus alternative myeloablative conditioning regimens in allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia 423
Allogeneic stem cell transplantation for agnogenic myeloid metaplasia: a European Group for Blood and Marrow Transplantation, Société Française de Greffe de Moelle, Gruppo Italiano per il Trapianto del Midollo Osseo, and Fred Hutchinson Cancer Research Center Collaborative Study 422
Reduced intensity allogeneic transplantation in primary cutaneous t-cell lymphomas. 421
Relevance of bone marrow cell dose on allogeneic transplantation outcomes for patients with acute myeloid leukemia in first complete remission: results of a European survey 420
Clinical and biological aspects of acute monocytic leukemia (a retrospective study of 29 patients) 419
Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia 419
Allogeneic stem cell transplant from HLA-identical sibling for chronic granulomatous disease and review of the literature 418
Minimal Residual Disease in Acute Myeloid Leukemia of Adults: Determination, Prognostic Impact and Clinical Applications 418
Umbilical Cord Blood Transplantation From Unrelated Donors In Patients With Ph-Positive Acute Lymphoblastic Leukemia. 418
Total parenteral nutrition enriched with glutamine and ω-3 fatty acid in adult patients undergoing autologous stem cell transplantation. 417
Unrelated cord blood transplantation for childhood acute myeloid leukemia: a Eurocord Group analysis 414
Involvement of central nervous system in adult patients with acute myeloid leukemia: Incidence and impact on outcome 412
Monitoring of minimal residual disease in acute myeloid leukemia 411
A single high dose of idarubicin combined with high-dose ARA-C for treatment of first relapse in childhood 'high-risk' acute lymphoblastic leukaemia: a study of the AIEOP group 411
Extracorporeal photochemotherapy in the treatment of acute and chronic GvHD: experience from Rome Transplant Network 411
High-dose therapy and autologous stem-cell transplantation in waldenstrom macroglobulinemia: the lymphoma working party of the european group for blood and marrow transplantation 411
Development of cellulitis caused by Aeromonas hydrophila in allogeneic hematopoietic transplantation: a case report. 408
N-acetylcysteine in the treatment of steroid-resistant acute graft-versus-host-disease: preliminary results. Gruppo Italiano Trapianto di Midollo Osseo (GITMO) 407
Assessment of donor-derived kir by sequential cDNA genotyping in non t cell depleted haploidentical stem cell transplanted patients 406
Bone mass, bone metabolism, and prevalence of spinal fractures in recipients of allogenic bone marrow transplantation for leukemia 405
Nonpermissive HLA-DPB1 disparity is a significant independent risk factor for mortality after unrelated hematopoietic stem cell transplantation 405
Standard- versus high-dose lenograstim in adults with hematologic malignancies for peripheral blood progenitor cell mobilization. 404
The potential role of pre-transplant HBcIgG seroposivity as predictor of clinically relevant cytomegalovirus infection in patients with lymphoma undergoing autologous hematopoietic stem cell transplantation: A study from the Rome Transplant Network. 404
Management of advanced acute lymphoblastic leukemia in children and adults: results of the ALL R-87 protocol. AIEOP and GIMEMA Cooperative Groups 404
Monitoring treatment and survival in chronic myeloid leukemia. Italian Cooperative Study Group on Chronic Myeloid Leukemia and Italian Group for Bone Marrow Transplantation 404
Outcome of patients activating an unrelated donor search: the impact of transplant with reduced intensity conditioning in a large cohort of consecutive high-risk patients 404
Killer Cell Immunoglobulin-Like Receptor-Ligand Matching and Outcomes after Unrelated Cord Blood Transplantation in Acute Myeloid Leukemia 404
DIAGNOSTIC PERFORMANCE AND SAFETY OF BRONCHOALVEOLAR LAVAGE IN THROMBOCYTOPENIC HAEMATOLOGICAL PATIENTS FOR ASPERGILLOSIS DIAGNOSIS: A MONOCENTRIC, RETROSPECTIVE EXPERIENCE 404
HLA-C and HLA-DQB1 compatibility in unrelated cord blood transplants 403
Totale 45.058
Salva come PNG Salva come JPEG
Categoria #
all - tutte 203.585
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 203.585
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.858 0 0 0 102 66 192 140 138 143 154 168 755
2022/20232.748 352 238 134 261 170 655 325 133 213 17 189 61
2023/20241.008 99 47 78 25 101 232 57 39 28 23 16 263
2024/20255.336 170 1.243 571 316 66 225 449 212 536 582 467 499
2025/20268.238 573 501 1.069 678 698 305 1.033 966 1.044 650 370 351
2026/20272.993 408 446 1.565 574 0 0 0 0 0 0 0 0
Totale 84.970